Open Daily 9:30 to 19:00
Non Invasive Prenatal Test – NIPT uses advanced whole genome sequencing to screen for common chromosomal abnormalities with high accuracy. This non-invasive test provides early detection and includes information about the fetal gender. Results are available in 7 days.
Recommended gestational age
DETECTION RATE
Fetal Gender
Trisomy 21
Trisomy 18
Trisomy 13
NIPT Package
NIPT 5 Chromosome
Comprehensive in 5 Chromosome
- Fetal Gender
- Singleton / Twin
- Natural / IVF
- Down syndrome(Trisomy 21)
- Edwards’ syndrome (Trisomy 18)
- Patau’s Syndrome (Trisomy 13)
- Sex Chromosome abnormally
( XO, XYY, XXY, XXX )
NIPT All Chromosome
Comprehensive insights in All Chromosome
- Fetal Gender
- Singleton / Twin
- Natural / IVF
- Down Syndrome (Trisomy 21 )
- Edvards’ Syndrome (Trisomy 18)
- Patau’s Synsrome (Trisomy 13)
- Sex Chromosome abnormally
( XO, XYY, XXY, XXX ) - Trisomy 8, 9, 16, 22
- Other chromosome
A Guide to Non-Invasive Prenatal Testing (NIPT)
NIPT, or Non-Invasive Prenatal Testing, is a screening method that analyzes small fragments of fetal DNA in a pregnant woman’s blood to assess the risk of genetic conditions, particularly chromosomal abnormalities like Down syndrome (trisomy 21), trisomy 18, and trisomy 13. It is non-invasive, posing no risk to the fetus, and is known for its high accuracy. Results are typically available within a week or two. NIPT is often recommended for women with higher risks, such as advanced maternal age or family history of genetic disorders. The sample type used is a blood sample from the mother.
Contact Medpro
Explore Medpro
Medpro Laboratory Clinic



